Toxicities of drugs used in the management of fever

Clinical Infectious Diseases

Volumn 31, Issue SUPPL. 5, 2000, Pages

  Plaisance, K I ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; IBUPROFEN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DRUG MECHANISM; DRUG SAFETY; FEVER; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TOXICITY; NEPHROTOXICITY; PRIORITY JOURNAL;

ACETAMINOPHEN; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DIGESTIVE SYSTEM; FEVER; HUMANS; ISOENZYMES; KIDNEY; LIVER; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;

EID: 0034456039     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317518     Document Type: Conference Paper

References (30)

1. Nonrenal toxicities of acetaminophen, aspirin, and nonsteroidal anti-inflammatory agents
2. Reye's syndrome in the United States from 1981 through 1997
3. Therapeutic misadventures with acetaminophen: Hepatoxicity after multiple doses in children
4. Acetaminophen: Acute and chronic effects on renal function
5. Epidemiology of NSAID induced gastrointestinal complications
6. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen
7. Gastrointestinal tract complications of non-steroidal antiinflammatory drug treatment in rheumatoid arthritis: A prospective observational cohort study
8. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage
9. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs
10. Gastric adaptation: Studies in humans during continuous aspirin administration
11. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs: A meta-analysis
12. The renal effects of nonsteroidal antiinflammatory drugs: Summary and recommendations
13. Analgesic use and chronic renal failure: A critical review of the epidemiologic literature
14. Acetaminophen and adverse chronic renal outcomes: An appraisal of the epidemiologic evidence
15. Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation
16. Acetaminophen toxicity in an urban county hospital
17. Association of acetaminophen hepatotoxicity with fasting and alcohol use
18. Acetaminophen overdose with therapeutic intent
19. An assessment of the safety of pediatric ibuprofen: A practitioner-based randomized clinical trial
20. Renal function after short-term ibuprofen use in infants and children
21. The safety of acetaminophen and ibuprofen among children younger than two years old
22. Ibuprofen and/or acetaminophen: What price for "euthermia"?
23. Antipyretic therapy: Physiologic rationale, diagnostic implications, and clinical consequences
24. Reply to combined antipyretic therapy: Another potential source of chronic acetaminophen toxicity
25. Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans
26. COX-1-sparing NSAIDs: Is the enthusiasm justified?
27. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: A randomized controlled trial
28. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
29. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs)
30. Rationalizing cyclooxygenase (COX) inhibition for maximal efficacy and minimal adverse events